Breast cancer cells treated with T3 triggered a significant increase of phospho-paxillinTyr118 at the cell membrane periphery where cortical actin complexes were formed, and this was impaired by the blockade of Src (PP2), FAK (FAKi), and paxillin (siRNAs) (Figures 3E,F). Here, SRC is linked to breast cancer.